Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Director | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Ending reported balance
After 2026-06-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-06-15 · Other · Disposed 2,934 · Balance 69,566 F1: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F2: Represents shares of common stock transferred to Health Partners. Row 2 · 2026-06-15 · Other · Disposed 34,932 · Balance 34,634 F1: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F3: Represents shares of common stock transferred to Cayman Master. Row 3 · 2026-06-15 · Other · Disposed 4,634 · Balance 30,000 F1: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F4: Represents shares of common stock transferred to Select Opportunities. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration.
F2: Represents shares of common stock transferred to Health Partners.
F3: Represents shares of common stock transferred to Cayman Master.
F4: Represents shares of common stock transferred to Select Opportunities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 4,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 3 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F4 · shares: Represents shares of common stock transferred to Select Opportunities. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 34,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 2 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,634 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F3 · shares: Represents shares of common stock transferred to Cayman Master. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:57 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 2,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-274343 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,566 F1 · kind: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration. F2 · shares: Represents shares of common stock transferred to Health Partners. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:59 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002044406-26-000002 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,500 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077826 · ownership.xml · nonDerivative · entry 1 Amin Avinash · CIK 0002044406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.